CN Patent

CN121729496A — 靶向凝血因子xi的双链核糖核酸

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2026-03-24 · 0y expired

What this patent protects

提供一种靶向凝血因子XI的双链核糖核酸、其药学上可接受的盐或其配体缀合物，还提供了包含所述双链核糖核酸、其药学上可接受的盐或其配体缀合物的药物组合物，以及所述双链核糖核酸、其药学上可接受的盐或其配体缀合物的治疗用途。

USPTO Abstract

提供一种靶向凝血因子XI的双链核糖核酸、其药学上可接受的盐或其配体缀合物，还提供了包含所述双链核糖核酸、其药学上可接受的盐或其配体缀合物的药物组合物，以及所述双链核糖核酸、其药学上可接受的盐或其配体缀合物的治疗用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN121729496A
Jurisdiction
CN
Classification
—
Expires
2026-03-24
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.